We are live on ! Find out more
ACP

Aveo Capital Partners Portfolio holdings

AUM $601M
1-Year Est. Return 5.92%
This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+5.92%
3 Year Est. Return
+19.07%
5 Year Est. Return
+62.74%
10 Year Est. Return
AUM
$665M
AUM Growth
+$84.7M
Cap. Flow
+$55.8M
Cap. Flow %
8.39%
Top 10 Hldgs %
30.85%
Holding
348
New
78
Increased
145
Reduced
97
Closed
19

Sector Composition

Rank Sector Weight
1 Energy 2.07%
2 Healthcare 1.88%
3 Technology 1.57%
4 Consumer Staples 1.03%
5 Financials 1.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
226
Amgen
AMGN
$218B
$385K 0.06%
1,466
-336
-19% -$90.1K
EMB icon
227
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$385K 0.06%
4,547
-2,605
-36% -$215K
EFV icon
228
iShares MSCI EAFE Value ETF
EFV
$29.2B
$383K 0.06%
8,337
-74,161
-90% -$3.22M
VGT icon
229
Vanguard Information Technology ETF
VGT
$147B
$380K 0.06%
9,520
+3,240
+52% +$132K
RTX icon
230
RTX Corp
RTX
$300B
$378K 0.06%
3,742
-202
-5% -$19K
IBM icon
231
IBM
IBM
$223B
$377K 0.06%
2,674
+396
+17% +$54.6K
BAC icon
232
Bank of America
BAC
$444B
$376K 0.06%
11,353
+1,252
+12% +$43.1K
KNTK icon
233
Kinetik
KNTK
$3.55B
$373K 0.06%
11,282
+2,257
+25% +$76.9K
ABBV icon
234
AbbVie
ABBV
$433B
$371K 0.06%
2,299
+96
+4% +$14.7K
BLDR icon
235
Builders FirstSource
BLDR
$8.21B
$368K 0.06%
5,674
+2,049
+57% +$128K
LH icon
236
Labcorp
LH
$25.5B
$367K 0.06%
1,815
+297
+20% +$58K
COST icon
237
Costco
COST
$417B
$357K 0.05%
781
+142
+22% +$69.4K
UTHR icon
238
United Therapeutics
UTHR
$21.8B
$355K 0.05%
1,275
-45
-3% -$11.4K
VRTX icon
239
Vertex Pharmaceuticals
VRTX
$123B
$351K 0.05%
1,216
+330
+37% +$101K
EXPD icon
240
Expeditors International
EXPD
$23.8B
$350K 0.05%
3,364
+548
+19% +$56.5K
DVN icon
241
Devon Energy
DVN
$48.7B
$348K 0.05%
5,663
-984
-15% -$67.1K
FXG icon
242
First Trust Consumer Staples AlphaDEX Fund
FXG
$228M
$346K 0.05%
5,507
FXO icon
243
First Trust Financials AlphaDEX Fund
FXO
$1.15B
$344K 0.05%
8,409
+36
+0.4% +$1.48K
VMBS icon
244
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$342K 0.05%
7,510
-54,724
-88% -$2.48M
MBB icon
245
iShares MBS ETF
MBB
$39.1B
$341K 0.05%
3,681
-5,243
-59% -$484K
FISR icon
246
State Street Fixed Income Sector Rotation ETF
FISR
$494M
$340K 0.05%
+13,288
New +$340K
TMO icon
247
Thermo Fisher Scientific
TMO
$213B
$339K 0.05%
615
+154
+33% +$81.6K
PSA icon
248
Public Storage
PSA
$61.2B
$335K 0.05%
1,197
-17
-1% -$4.96K
KNX icon
249
Knight Transportation
KNX
$11.6B
$333K 0.05%
6,358
+1,368
+27% +$70.7K
TQQQ icon
250
ProShares UltraPro QQQ
TQQQ
$37.4B
$332K 0.05%
38,400
+9,000
+31% +$91.3K

Similar funds

Aveo Capital Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Aveo Capital Partners held 348 positions worth $665M, up 15% from $580M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Aveo Capital Partners deployed $55.8M of net new capital in Q4 2022, opening 78 new positions and adding to 145 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 136,290 shares worth $12.3M.

By sector, the portfolio is most concentrated in Energy at 2.1% of assets, up from 1.8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was iShares 0-3 Month Treasury Bond ETF, an estimated $33.8M trimmed.

  • Aveo Capital Partners's largest Q4 2022 buy was State Street SPDR Bloomberg High Yield Bond ETF: 136,290 shares worth $12.3M.
  • Aveo Capital Partners added most to Invesco RAFI Strategic US ETF in Q4 2022, an estimated $13.8M increase.
  • Aveo Capital Partners's biggest Q4 2022 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $33.8M.
  • Aveo Capital Partners fully exited ProShares Ultra QQQ in Q4 2022, selling an estimated $6.07M.
  • Aveo Capital Partners's ten largest holdings make up 31% of its $665M portfolio in Q4 2022.
  • Aveo Capital Partners opened 78 new positions and closed 19 in Q4 2022.
  • Aveo Capital Partners's portfolio value rose 15% quarter-over-quarter to $665M.

Based on Aveo Capital Partners's 13F filing for Q4 2022, filed 3 Feb 2023.